MedPath

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002

Approved
Approval ID

62abde41-46cb-4e90-a798-23d6531bf9aa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2024

Manufacturers
FDA

SpecGx LLC

DUNS: 080679498

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

PRODUCT DETAILS

NDC Product Code0406-8005
Application NumberANDA207000
Marketing CategoryC73584
Route of AdministrationSUBLINGUAL
Effective DateJanuary 3, 2024
Generic NameBuprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

INGREDIENTS (13)

BUPRENORPHINE HYDROCHLORIDEActive
Quantity: 2 mg in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
ACESULFAME POTASSIUMInactive
Code: 23OV73Q5G9
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
NALOXONE HYDROCHLORIDE DIHYDRATEActive
Quantity: 0.5 mg in 1 1
Code: 5Q187997EE
Classification: ACTIM

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

PRODUCT DETAILS

NDC Product Code0406-8020
Application NumberANDA207000
Marketing CategoryC73584
Route of AdministrationSUBLINGUAL
Effective DateJanuary 3, 2024
Generic NameBuprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

INGREDIENTS (13)

BUPRENORPHINE HYDROCHLORIDEActive
Quantity: 8 mg in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
ACESULFAME POTASSIUMInactive
Code: 23OV73Q5G9
Classification: IACT
NALOXONE HYDROCHLORIDE DIHYDRATEActive
Quantity: 2 mg in 1 1
Code: 5Q187997EE
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate - FDA Drug Approval Details